Trial intelligence / Profile preview

Norditropin for Nutritional Status in Hemodialysis

NCT00184652Phase 2Completed

Sponsor
Novo Nordisk
Start
Apr 2003
Primary completion
Sep 2005
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
9
01

Overview

A Phase 2 trial of somatropin in end stage renal disease (ESRD), sponsored by Novo Nordisk. Started Apr 2003; status: completed.

02

Drugs

somatropin
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT00184652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00184652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call